European regulators have good news for Amgen on cancer drugs
One of the world’s most expensive cancer drugs got conditional approval from European regulators on Sept. 25. Europeans granted Thousand Oaks-based Amgen conditional approval of its rare blood cancer drug Blincyto and gave a positive evaluation of Amgen’s multiple-myeloma drug Kyprolis. Blincyto is an immunotherapy that is designed to treat a rare form of leukemia Read More →
Read More →
Industry titans ponder future of digital music
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Startups race to find investors at Cal Poly San Luis Obispo Demo Day
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Industry titans debate future of digital music
Three titans of the music industry had mixed views of the future of digital music and artists’ ability to profit from it during a panel discussion in Santa Barbara Wednesday evening. The MIT Enterprise Forum of the Central Coast featured Tom Conrad, co-founder and retired chief technology officer of Pandora; Marc Geiger, head of the Read More →
Read More →Hewlett-Packard laying off 25,000 to 30,000 employees
Hewlett-Packard is laying off 25,000 to 30,000 employees globally as part of a restructuring program that will save the company $2.7 billion per year. HP announced the layoffs on Sept. 15 at a meeting of its securities analysts. The cuts represent about 10 percent of HP’s workforce of about 302,000. It wasn’t immediately clear how Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
